LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,635 Cr | ₹3,540 Cr | ₹3,112 Cr | ₹2,432 Cr | ₹2,681 Cr |
What is the latest Total Current Liabilities ratio of LAURUS LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹3,635 Cr |
| Mar2025 | ₹3,540 Cr |
| Mar2024 | ₹3,112 Cr |
| Mar2023 | ₹2,432 Cr |
| Mar2022 | ₹2,681 Cr |
How is Total Current Liabilities of LAURUS LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,635 Cr | 2.70 | |
| Mar2025 | ₹3,540 Cr | 13.73 | |
| Mar2024 | ₹3,112 Cr | 27.96 | |
| Mar2023 | ₹2,432 Cr | -9.28 | |
| Mar2022 | ₹2,681 Cr | - | |
Compare Total Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹110,005.1 Cr | 1.8% | 3.3% | 139% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 1.8% |
3.3% |
139% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses